Literature DB >> 47998

Detection of circulating immune complexes in pathological human sera.

A H Johnson, J F Mowbray, K A Porter.   

Abstract

The results of attempts to detect circulating immune complexes in sera by two methods are described. Both rely on the binding of the first complement component (C1) to the complex for its detection. The results, using these methods, of attempts to show which patients have complexes which contain nucleic acid and hence possibly viral antigens in the complexes are discussed. The anti-complementary complexes found in some patients seem to be associated with immune-complex vascular disease.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 47998     DOI: 10.1016/s0140-6736(75)92433-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  31 in total

1.  Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1.

Authors:  G Füst; G A Medgyesi; E Rajnavölgyi; M Csécsi-Nagy; K Czikora; J Gergely
Journal:  Immunology       Date:  1978-12       Impact factor: 7.397

2.  Circulating and deposited immune complexes in renal disease and their clinical correlation.

Authors:  S L Cohen; C Fisher; J F Mowbray; A Hopp; J Burton-Kee
Journal:  J Clin Pathol       Date:  1979-11       Impact factor: 3.411

3.  Circulating immune complexes in retinal vasculitis.

Authors:  B S Andrews; J McIntosh; V Petts; R Penny
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

4.  Immune complexes in ulcerative colitis and Crohn's disease.

Authors:  H J Hodgson; B J Potter; D P Jewell
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

5.  Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q.

Authors:  F C Hay; L J Nineham; I M Roitt
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

6.  Depressed classical complement pathway activities in chronic lymphocytic leukaemia.

Authors:  G Füst; E Czink; D Minh; Z Miszlay; L Varga; S R Hollán
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

7.  Studies on circulating soluble immune complexes of the liver disease. 6. Comparative studies of 125I-pRF inhibition assay, 125I-Clq inhibition assay and 125I-Clq binding assay.

Authors:  J Narumoto
Journal:  Gastroenterol Jpn       Date:  1981

8.  Neutropenia in rheumatoid arthritis: studies on possible contributing factors.

Authors:  R C Bucknall; P Davis; P A Bacon; J V Jones
Journal:  Ann Rheum Dis       Date:  1982-06       Impact factor: 19.103

9.  A new specific assay for the detection of DNA immune complexes: its relevance in SLE.

Authors:  P Klemp; O L Meyers; E H Harley
Journal:  Ann Rheum Dis       Date:  1983-06       Impact factor: 19.103

10.  Detection of circulating IgG aggregates and immune complexes using 125I protein A from Staphylococcus aureus.

Authors:  R Hällgren; L Wide
Journal:  Ann Rheum Dis       Date:  1976-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.